Subscribe To
Travere: sparsentan approval is likely, but future is uncertain
IgA Nephropathy (IgAN) is a chronic autoimmune disease that affects the kidneys and leads to end-stage kidney disease. Current ...
February 13, 2023, 5:23 pm
Chinook's atrasentan: a promising solution for iga nephropathy?
Chinook is a clinical-stage biopharmaceutical firm that is developing precision medicines for kidney diseases, including ...
February 13, 2023, 3:02 pm
Daxxify™ is now available at rockland’s skin klinic & day spa
The Aesthetic-Focused Team Began Offering a New, Longer-Lasting Wrinkle Relaxer Starting December 2022 ROCKLAND, Maine, Feb. 08, 2023 (GLOBE NEWSWIRE)...
February 8, 2023, 10:12 pm
Pulmonx to report fourth quarter and full year 2022 financial results on february 22, 2023
REDWOOD CITY, Calif., Feb. 08, 2023 (GLOBE NEWSWIRE) — Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive
February 8, 2023, 9:05 pm
Design therapeutics to participate in the svb securities virtual global biopharma conference
CARLSBAD, Calif., Feb. 08, 2023 (GLOBE NEWSWIRE) — Design Therapeutics, Inc. (Nasdaq: DSGN), a clinical-stage biotechnology company developing ...
February 8, 2023, 11:30 am
Isoray inc. and viewpoint molecular targeting inc. announce name change to perspective therapeutics inc.
Company’s focus is on the advancement of cancer treatments using radiation, radiopharmaceuticals, and...
February 7, 2023, 10:48 pm
Larimar therapeutics appoints dr. gopi shankar as chief development officer
Biologics expert and long-time veteran of Johnson & Johnson will be responsible for the strategic development of Larimar’s clinical and R&D programs...
February 7, 2023, 9:05 pm
Poseida therapeutics: new allogeneic therapies, leveraging non-viral engineering
Poseida Therapeutics, Inc. granted Takeda its worldwide license to gene-therapy technologies that included piggyBac, Cas-Clover, and biodegradable DNA...
February 6, 2023, 4:54 pm
Labcorp's (lh) new launches, planned spinoff to aid growth
In terms of portfolio enhancement, LabCorp (LH) enters into a collaboration with Becton, Dickinson and Company to advance in life-changing ...
February 6, 2023, 1:33 pm
Global antibody-mediation rejection prevention market to rise at a staggering 16% cagr until 2033; mabs to be frequently deployed treatment approach: future market insights, inc. study
The antibody-mediated rejection prevention market in the United States and United Kingdom is a rapidly growing segment of the healthcare industry. Ant...
February 6, 2023, 10:30 am
Vera therapeutics announces pricing of public offering of class a common stock
BRISBANE, Calif., Feb. 01, 2023 (GLOBE NEWSWIRE) — Vera Therapeutics, Inc., (NasdaqGM: VERA; “Vera”), a late-stage biotechnology company focused...
February 2, 2023, 2:52 am
Novo nordisk lifts dividend, launches $4.09 billion share buyback after earnings beat forecasts
Danish pharmaceutical company Novo Nordisk AS DK:NOVO.B NVO on Wednesday raised its dividend and launched a new 28 billion Danish kroner ($4.09 billio...
February 1, 2023, 2:25 am
Pfizer posts record-breaking 2022 full-year revenue of $100b but expects that to fall by 33% in 2023
Pfizer Inc (NYSE:PFE) posted record-high revenue of $100.3 billion in 2022, fueled by more than $50 billion in sales of its Covid-19 vaccine and ...
January 31, 2023, 11:20 am
Evoke announces teva ends pursuit of paragraph iv anda against gimoti
Stipulation of Dismissal of Claims, Defenses and Counterclaims for Patent Infringement Case Filed SOLANA BEACH, Calif., Jan. 30, 2023 (GLOBE NEWSWIRE)...
January 30, 2023, 12:00 pm
Irwin naturals announces loi to acquire braxia scientific to create new market leader
Irwin Naturals Inc. (CSE:IWIN) said it has entered into a non-binding amended and restated Letter of Intent (LOI) for a business combination with Bra...
January 27, 2023, 8:25 am
3 drug stocks with promising pipelines for 2023
The world of pharmaceutical progress happens incrementally and exponentially. That is, therapies are iteratively improved while breakthrough ...
January 23, 2023, 10:03 am
Catalent, inc. announces second quarter fiscal year 2023 earnings conference webcast
SOMERSET, N.J.--( BUSINESS WIRE )--Catalent, Inc. (NYSE: CTLT), the global leader in enabling pharma, biotech, and consumer health partners to optimiz...
January 20, 2023, 8:38 am
Mineralys therapeutics builds on phase 2 trial success with ipo filing
Mineralys Therapeutics has filed to raise drug candidate development funding via a U.S. IPO. The firm is developing ...
January 19, 2023, 10:45 pm
Indivior: healthy defensive in a difficult economy
Drug addiction is on the rise but so are treatments for it, like those provided by Indivior for opioid ...
January 18, 2023, 5:51 pm
Anavex: drug treatments for early alzheimer's disease
Anavex 2-73/blarcamesine at high concentrations in early Alzheimer's disease leads to improvements in cognition and activities of daily living that ar...
January 17, 2023, 5:10 pm